Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

January 01, 1995; Volume 23,Issue 1
  • You have access
    Metabolism of a candidate 8-aminoquinoline antimalarial agent, WR 238605, by rat liver microsomes.
    O R Idowu, J O Peggins, T G Brewer and C Kelley
    Drug Metabolism and Disposition January 1995, 23 (1) 1-17;
  • You have access
    Side-chain hydroxylation in the metabolism of 8-aminoquinoline antiparasitic agents.
    O R Idowu, J O Peggins and T G Brewer
    Drug Metabolism and Disposition January 1995, 23 (1) 18-27;
  • You have access
    Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506.
    K Iwasaki, T Shiraga, H Matsuda, K Nagase, Y Tokuma, T Hata, Y Fujii, S Sakuma, T Fujitsu and A Fujikawa
    Drug Metabolism and Disposition January 1995, 23 (1) 28-34;
  • You have access
    Ocular absorption, distribution, and systemic absorption of a novel antiglaucoma medication, prostaglandin derivative, in male white rabbits.
    K Higaki, K Kamata, M Takeuchi, K Inazawa, T Chikai, T Hamaguchi, T Yukawa, K Kadono, S Kawahara and M Nakano
    Drug Metabolism and Disposition January 1995, 23 (1) 35-43;
  • You have access
    Infection (Actinobacillus pleuropneumoniae)-mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in pigs.
    M Monshouwer, R F Witkamp, S M Nijmeijer, L A Van Leengoed, J H Verheijden and A S Van Miert
    Drug Metabolism and Disposition January 1995, 23 (1) 44-47;
  • You have access
    Biosynthesis of S-(2-chloro-1,1,2-trifluoroethyl)glutathione in rat and human hepatocytes and in Hep G2 cells.
    E Tanaka and M W Anders
    Drug Metabolism and Disposition January 1995, 23 (1) 48-54;
  • You have access
    Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate.
    Y S Kang, R J Boado and W M Pardridge
    Drug Metabolism and Disposition January 1995, 23 (1) 55-59;
  • You have access
    Isoflurane-chlorodifluoroethene interaction in human liver microsomes. Role of cytochrome P4502B6 in potentiation of haloethene metabolism.
    M T Baker, M J Olson, Y Wang, W C Ronnenberg, J T Johnson and A N Brady
    Drug Metabolism and Disposition January 1995, 23 (1) 60-64;
  • You have access
    In vitro and in vivo biotransformations of the naphthalenic lignan lactone 5-lipoxygenase inhibitor, L-702,539.
    N Chauret, C Li, Y Ducharme, L A Trimble, J A Yergey, C Ramachandran and D A Nicoll-Griffith
    Drug Metabolism and Disposition January 1995, 23 (1) 65-71;
  • You have access
    Xenopus laevis: a model system for the study of embryonic retinoid metabolism. I. Embryonic metabolism of 9-cis- and all-trans-retinals and retinols to their corresponding acid forms.
    J C Kraft, D Kimelman and M R Juchau
    Drug Metabolism and Disposition January 1995, 23 (1) 72-82;
  • You have access
    Xenopus laevis: a model system for the study of embryonic retinoid metabolism. II. Embryonic metabolism of all-trans-3,4-didehydroretinol to all-trans-3,4-didehydroretinoic acid.
    J Creech Kraft, D Kimelman and M R Juchau
    Drug Metabolism and Disposition January 1995, 23 (1) 83-89;
  • You have access
    Pharmacokinetics and bioavailability of topiramate in the beagle dog.
    A J Streeter, P L Stahle, M L Holland, J F Pritchard and A R Takacs
    Drug Metabolism and Disposition January 1995, 23 (1) 90-93;
  • You have access
    Biotransformation of CI-937 in primary cultures of rat hepatocytes. Formation of glutathione conjugates.
    U Renner, J Blanz, S Freund, D Waidelich, G Ehninger and K P Zeller
    Drug Metabolism and Disposition January 1995, 23 (1) 94-101;
  • You have access
    Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopy.
    M K Ellis, J L Naylor, T Green and M A Collins
    Drug Metabolism and Disposition January 1995, 23 (1) 102-106;
  • You have access
    Metabolism of the nephrotoxicant N-(3,5-dichlorophenyl)succinimide by isolated rat hepatocytes.
    A K Nyarko and P J Harvison
    Drug Metabolism and Disposition January 1995, 23 (1) 107-112;
  • You have access
    Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver.
    A Magistrelli, P Villa, E Benfenati, E J Modest, M Salmona and M T Tacconi
    Drug Metabolism and Disposition January 1995, 23 (1) 113-118;
  • You have access
    Characterization and formation of the glutathione conjugate of clofibric acid.
    L J Shore, C Fenselau, A R King and R G Dickinson
    Drug Metabolism and Disposition January 1995, 23 (1) 119-123;
  • You have access
    Metabolism of [14C]- and [35S]S-(1,2-dichlorovinyl)-L-cysteine in the male Fischer 344 rat.
    M B Finkelstein, N J Patel and M W Anders
    Drug Metabolism and Disposition January 1995, 23 (1) 124-128;
  • You have access
    Metabolism of [14C]naphthalene in the B6C3F1 murine isolated perfused liver.
    L S Tsuruda, M W Lamé and A D Jones
    Drug Metabolism and Disposition January 1995, 23 (1) 129-136;
  • You have access
    Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
    G Jönsson, A Aström and P Andersson
    Drug Metabolism and Disposition January 1995, 23 (1) 137-142;
  • You have access
    Nicotine and cotinine accumulation in pigmented and unpigmented rat hair.
    B Gerstenberg, G Schepers, P Voncken and H Völkel
    Drug Metabolism and Disposition January 1995, 23 (1) 143-148;
  • You have access
    Stereoselective glucuronidation of zileuton isomers by human hepatic microsomes.
    D J Sweeny and H N Nellans
    Drug Metabolism and Disposition January 1995, 23 (1) 149-153;
  • You have access
    Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
    D J Newton, R W Wang and A Y Lu
    Drug Metabolism and Disposition January 1995, 23 (1) 154-158;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 1
1 Jan 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics